Medicines
Influenza Vaccine Composition
The recommended influenza vaccine composition for New Zealand in 2012 is:
- A(H1N1): an A/California/7/2009 (H1N1)-like strain, 15 μg HA per dose
- A(H3N2): an A/Perth/16/2009 (H3N2)-like strain, 15 μg HA per dose
- B: a B/Brisbane/60/2008-like strain, 15 μg HA per dose
Vaccine strains recommended as suitable are those listed on
the World Health Organisation (WHO) Influenza vaccine viruses
and reagents web pages (see
http://www.who.int/influenza/vaccines/virus/en/) for H1N1,
H3N2 and B-Victoria lineage viruses.
This recommendation is based on the outcome of:
- The meeting of the Australian Influenza Vaccine
Committee, with a New Zealand representative, to consult on
the influenza vaccine composition for 2012 (held on 5
October 2011),
- Information on international surveillance by the WHO
Global Influenza Surveillance Network,
- Analysis of recent data on epidemiology and strain
characterisation, and
- The recommendations of the WHO annual consultation on
the composition of 2012 influenza vaccine for the Southern
Hemisphere.